Protalix BioTherapeutics (PLX)

• Market cap: $174M
• 1 day: 1.89%
• 5 days: 9.09%
• 1 month: 1.89%
• 3 months: -28.71%
• 6 months: 21.35%
• Year to date: 24.14%
• 1 year: 35.85%
• 5 years: -28.95%
• 10 years: -73%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Employees: 226